Literature DB >> 1904422

Four forms of cytochrome P-450 in human fetal liver: purification and their capacity to activate promutagens.

M Kitada1, M Taneda, K Itahashi, T Kamataki.   

Abstract

Four forms of cytochrome P-450 were separated and purified to electrophoretic homogeneity from human fetal livers. These forms of cytochrome P-450, termed P-450HFLa, P-450HFLb, P-450HFLc and P-450HFLd, were distinguishable from each other in their molecular weights, spectral properties, immunochemical properties and mutagen-producing activities from promutagens. The molecular weights of P-450HFLa, b, c and d were estimated to be 51,500, 49,000, 51,500 and 50,000, respectively. Antibodies to P-450HFLa recognized P-450HFLc but not P-450HFLb or d, and antibodies to rat P-448-H (P-450IA2) cross-reacted with P-450HFLb but not with other forms of cytochrome P-450. The N-terminal amino acid sequence of P-450HFLc was highly homologous, but not identical, to that of P-450HFLa. Each form of cytochrome P-450 catalyzed mutagenic activation of aflatoxin B1 (AFB1), 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-6-methyldipyrido-[1,2-a:3',2'-d]imidazole (Glu-P-1) at different rates. P-450 HFLa showed activities to produce mutagen(s) from AFB1, IQ and to a lesser extent from Glu-P-1. P-450 HFLb activated IQ at a faster rate than did the other forms. P-450 HFLc produced a mutagen from AFB1 and Glu-P-1 but not from IQ. P-450 HFLd did not activate these promutagens at significant rates.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1904422      PMCID: PMC5918441          DOI: 10.1111/j.1349-7006.1991.tb01866.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


ethylenediaminetetraacetic acid phenylmethylsulfonyl fluoride dithiothreitol fast protein liquid chromatography sodium dodecyl sulfate polyacrylamide gel electrophorests aflatoxin Bl 2‐amino‐3‐methylimidazo[4,5‐f]quino‐line 2‐amino‐6‐methyldipyrido [l,2‐a:3′,2′‐d] imidazole dilauroyl‐L‐3‐phosphatidylcholine
  32 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  Isolation and characterization of human fetal liver cytochrome P450HLp2: a third member of the P450III gene family.

Authors:  S A Wrighton; M Vandenbranden
Journal:  Arch Biochem Biophys       Date:  1989-01       Impact factor: 4.013

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues: detection by the polymerase chain reaction.

Authors:  C J Omiecinski; C A Redlich; P Costa
Journal:  Cancer Res       Date:  1990-07-15       Impact factor: 12.701

5.  Fetus-specific expression of a form of cytochrome P-450 in human livers.

Authors:  M Komori; K Nishio; M Kitada; K Shiramatsu; K Muroya; M Soma; K Nagashima; T Kamataki
Journal:  Biochemistry       Date:  1990-05-08       Impact factor: 3.162

6.  Studies of the metabolism of diethyl p-nitrophenyl phosphorothionate (parathion) and benzphetamine using an apparently homogeneous preparation of rat liver cytochrome P-450: effect of a cytochrome P-450 antibody preparation.

Authors:  T Kamataki; D H Belcher; R A Neal
Journal:  Mol Pharmacol       Date:  1976-11       Impact factor: 4.436

7.  Drug-metabolizing enzymes in human foetal liver: partial resolution of multiple cytochromes P 450.

Authors:  T Cresteil; P Beaune; P Kremers; J P Flinois; J P Leroux
Journal:  Pediatr Pharmacol (New York)       Date:  1982

8.  Cytochrome P-450-mediated activation of procarcinogens and promutagens to DNA-damaging products by measuring expression of umu gene in Salmonella typhimurium TA1535/pSK1002.

Authors:  T Shimada; S Nakamura
Journal:  Biochem Pharmacol       Date:  1987-06-15       Impact factor: 5.858

9.  A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Catalytic characterization and immunochemical quantitation in liver microsomes.

Authors:  T Kamataki; K Maeda; Y Yamazoe; N Matsuda; K Ishii; R Kato
Journal:  Mol Pharmacol       Date:  1983-07       Impact factor: 4.436

10.  Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002.

Authors:  T Shimada; M Iwasaki; M V Martin; F P Guengerich
Journal:  Cancer Res       Date:  1989-06-15       Impact factor: 12.701

View more
  3 in total

Review 1.  Approaches for assessing risks to sensitive populations: lessons learned from evaluating risks in the pediatric population.

Authors:  Ronald N Hines; Dana Sargent; Herman Autrup; Linda S Birnbaum; Robert L Brent; Nancy G Doerrer; Elaine A Cohen Hubal; Daland R Juberg; Christian Laurent; Robert Luebke; Klaus Olejniczak; Christopher J Portier; William Slikker
Journal:  Toxicol Sci       Date:  2009-09-21       Impact factor: 4.849

2.  Bioactivation of fluorinated 2-aryl-benzothiazole antitumor molecules by human cytochrome P450s 1A1 and 2W1 and deactivation by cytochrome P450 2S1.

Authors:  Kai Wang; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-07-10       Impact factor: 3.739

Review 3.  Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism.

Authors:  Haixing Li; Jed N Lampe
Journal:  Arch Biochem Biophys       Date:  2019-08-22       Impact factor: 4.013

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.